Literature DB >> 16186783

Postpartum hemorrhage and transfusion of blood and blood components.

A J G Jansen1, D J van Rhenen, E A P Steegers, J J Duvekot.   

Abstract

UNLABELLED: Postpartum hemorrhage (PPH) is one of the top 5 causes of maternal mortality in developed and developing countries. The incidence of PPH is 40% after vaginal delivery and 30% after cesarean section. Criteria for PPH are based on the amount of blood loss. In clinical obstetrics, exact measurement of blood loss is often difficult. The most important treatment of PPH is red blood cell (RBC) transfusion. In the past few years, increasing concern has arisen about this treatment. Despite the introduction of several new guidelines, transfusion criteria still vary widely between clinicians. The decision whether to prescribe RBC transfusion is mostly based on postpartum hemoglobin (Hb) values. RBC transfusion should be aimed to reduce morbidity and especially to improve health-related quality of life (HRQoL). In this review, etiology, epidemiology, treatment, and prevention of postpartum hemorrhage are described. Special attention is given to the role of RBC transfusion in the treatment of PPH and the effects of RBC transfusion on HRQoL. TARGET AUDIENCE: Obstetricians & Gynecologists, Family Physicians. LEARNING
OBJECTIVES: After completion of this article, the reader should be able to summarize the new guidelines related to transfusion criteria, explain the importance of reducing morbidity related to improving quality of life issues, and list infectious and noninfectious complications of a red blood cell transfusion.

Entities:  

Mesh:

Year:  2005        PMID: 16186783     DOI: 10.1097/01.ogx.0000180909.31293.cf

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  12 in total

1.  Prevalence and risk factors of anemia among pregnant women attending a high-volume tertiary care center for delivery.

Authors:  Cüneyt Eftal Taner; Atalay Ekin; Ulaş Solmaz; Cenk Gezer; Birgül Çetin; Mustafa Keleşoğlu; Merve Bayrak Erpala; Mehmet Özeren
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-11-02

2.  The impact of human immunodeficiency virus infection on obstetric hemorrhage and blood transfusion in South Africa.

Authors:  Evan M Bloch; Robert L Crookes; Jennifer Hull; Sue Fawcus; Rajesh Gangaram; John Anthony; Charlotte Ingram; Solomuzi Ngcobo; Julie Croxford; Darryl V Creel; Edward L Murphy
Journal:  Transfusion       Date:  2015-03-16       Impact factor: 3.157

3.  The Effect of Von Willebrand Disease on Pregnancy, Delivery, and Postpartum Period: A Retrospective Observational Study.

Authors:  Mateja Sladič; Ivan Verdenik; Špela Smrkolj
Journal:  Medicina (Kaunas)       Date:  2022-06-07       Impact factor: 2.948

4.  Acute aortic dissection in pregnant women.

Authors:  Zhaohua Yang; Shouguo Yang; Fangshun Wang; Chunsheng Wang
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-08-02

5.  The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial.

Authors:  Anne Juul Wikkelsoe; Arash Afshari; Jakob Stensballe; Jens Langhoff-Roos; Charlotte Albrechtsen; Kim Ekelund; Gabriele Hanke; Heidi Fosgrau Sharif; Anja U Mitchell; Jens Svare; Ane Troelstrup; Lars Møller Pedersen; Jeannet Lauenborg; Mette Gøttge Madsen; Birgit Bødker; Ann M Møller
Journal:  Trials       Date:  2012-07-17       Impact factor: 2.279

6.  Well being of obstetric patients on minimal blood transfusions (WOMB trial).

Authors:  Babette W Prick; Eric A P Steegers; A J Gerard Jansen; Wim C J Hop; Marie-Louise Essink-Bot; Nina C J Peters; Carin A Uyl-de Groot; Dimitri N M Papatsonis; Bettina M C Akerboom; Godfried C H Metz; Henk A Bremer; Aren J van Loon; Rob H Stigter; Joris A M van der Post; Marcel van Alphen; Martina Porath; Robbert J P Rijnders; Marc E A Spaanderman; Daniela H Schippers; Kitty W M Bloemenkamp; Kim E Boers; Hubertina C J Scheepers; Frans J M E Roumen; Anneke Kwee; Nico W E Schuitemaker; Ben Willem J Mol; Dick J van Rhenen; Johannes J Duvekot
Journal:  BMC Pregnancy Childbirth       Date:  2010-12-16       Impact factor: 3.007

7.  Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands.

Authors:  C A G Holleboom; J van Eyck; S V Koenen; I A M Kreuwel; F Bergwerff; E C Creutzberg; H W Bruinse
Journal:  Arch Gynecol Obstet       Date:  2013-01-18       Impact factor: 2.344

8.  Lifesaving intraosseous access in a patient with a massive obstetric hemorrhage.

Authors:  Joey de Vogel; Roger Heydanus; Annemarie G M Mulders; Dina J C Smalbraak; Dimitri N M Papatsonis; Bastiaan M Gerritse
Journal:  AJP Rep       Date:  2011-11-11

9.  A history of repetitive cesarean section is a risk factor of anemia in healthy perimenopausal women: The Korea National Health and Nutrition Examination Survey 2010-2012.

Authors:  Jee Yoon Park; Sung Woo Lee
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

10.  Maternal 'near miss' collection at an Australian tertiary maternity hospital.

Authors:  Skandarupan Jayaratnam; Sonia Kua; Caroline deCosta; Richard Franklin
Journal:  BMC Pregnancy Childbirth       Date:  2018-06-11       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.